Comments on: Harvard’s Biederman: What J&J Money?

By: Dan

Dan — Sun, 01 Mar 2009 23:52:31 +0000

…the pres. of SBS (HM) is now the VP of J&J CNS and Pain…

By: Mike T

Mike T — Thu, 27 Nov 2008 19:51:33 +0000

Meg wrote: First, Harvard needs to fire this man. Then a criminal trial with him, J and J and Lilly execs needs to happen. >>> I second the motion ! I am emailing my Senators and US Rep. weekly on this and related matters.

By: Mithra Green

Mithra Green — Thu, 27 Nov 2008 11:20:26 +0000

If you keep doing the same thing, you’ll keep getting the same results. Our relationship with the medical industry is like a spouse who keeps returning to an abusive partner thinking “THIS time it will be different.”
It’s time to step away from the pharmacy counter and realize that no doctor, company or university will ever care more about your health than you. You alone are the final arbitor of what is best for you.

By: me

me — Thu, 27 Nov 2008 02:49:10 +0000

First, how is it possible to get a true diagnosis of bipolar disorder in kids that young? It’s hard enough to dx an adult, especially if the pt is bipolar II (as I am). Second, why would anyone subject their children to a trial like this?

I won’t take those meds myself. I discuss pros and cons with my doctor before the “Rx roulette” starts. As much as Big Pharma would have you believe, newer is not necessarily better (e.g. COX-2 inhibitors).

Revoke Biederman’s medical license, and ensure he can never again inflict harm in the guise of medical care.

By: Meg

Meg — Wed, 26 Nov 2008 21:26:27 +0000

First, Harvard needs to fire this man. Then a criminal trial with him, J and J and Lilly execs needs to happen. It is so overdue. There has been no justice for the families of those who have been killed and maimed by these drugs. And then the atypicals need to be banned for children/adolescents.

By: David M.

David M. — Wed, 26 Nov 2008 21:15:51 +0000

Biological Psychiatry is published by the Society of Biological Psychiatry. Here is a section from their ethics statement: Research involving human subjects should be constructed and implemented in a fashion which is commensurate with scientific principles already generally accepted. Specifically, an investigation should benefit the patient or add to the existing body of scientific knowledge.

http://www.sobp.org/i4a/pages/index.cfm?pageID=3304

This study only benefited the marketing department at a pharmaceutical company.

Somebody needs to notify the president of SBS who is Husseini Manji at the NIMH.